Susquehanna International Group
AZN icon

Susquehanna International Group’s AstraZeneca AZN Stock Holding History

Susquehanna International Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246M Buy
1,247,200
+658,700
+112% +$127M 0.03% 440
2025
Q4 		$108M Buy
588,500
+66,350
+13% +$11.6M 0.01% 833
2025
Q3 		$80.1M Buy
522,150
+145,900
+39% +$22.1M 0.01% 1031
2025
Q2 		$52.6M Sell
376,250
-140,000
-27% -$19.6M 0.01% 1135
2025
Q1 		$75.9M Sell
516,250
-416,300
-45% -$60.2M 0.01% 787
2024
Q4 		$122M Buy
932,550
+683,750
+275% +$95.7M 0.02% 601
2024
Q3 		$38.8M Buy
248,800
+45,300
+22% +$7.31M 0.01% 1266
2024
Q2 		$31.7M Sell
203,500
-462,500
-69% -$69.6M 0.01% 1310
2024
Q1 		$90.2M Buy
666,000
+128,800
+24% +$17.1M 0.02% 728
2023
Q4 		$72.4M Sell
537,200
-26,750
-5% -$3.48M 0.01% 839
2023
Q3 		$76.4M Sell
563,950
-639,150
-53% -$87.3M 0.02% 756
2023
Q2 		$172M Buy
1,203,100
+590,600
+96% +$86.9M 0.04% 394
2023
Q1 		$85M Sell
612,500
-140,950
-19% -$19M 0.02% 668
2022
Q4 		$103M Buy
753,450
+123,600
+20% +$15.5M 0.03% 539
2022
Q3 		$69.2M Buy
629,850
+176,350
+39% +$22.4M 0.02% 656
2022
Q2 		$60.8M Sell
453,500
-71,700
-14% -$9.41M 0.02% 742
2022
Q1 		$70.5M Sell
525,200
-119,200
-18% -$14.3M 0.01% 826
2021
Q4 		$75.4M Sell
644,400
-571,550
-47% -$67.3M 0.01% 862
2021
Q3 		$146M Buy
1,215,950
+379,600
+45% +$44.2M 0.02% 640
2021
Q2 		$101M Sell
836,350
-784,400
-48% -$86.1M 0.01% 781
2021
Q1 		$162M Sell
1,620,750
-287,450
-15% -$28.9M 0.03% 535
2020
Q4 		$192M Sell
1,908,200
-192,400
-9% -$20.4M 0.03% 433
2020
Q3 		$230M Buy
2,100,600
+1,571,800
+297% +$175M 0.04% 306
2020
Q2 		$55.9M Buy
528,800
+215,950
+69% +$22.3M 0.01% 768
2020
Q1 		$27.9M Buy
312,850
+116,850
+60% +$11M 0.01% 980
2019
Q4 		$19.5M Sell
196,000
-56,600
-22% -$5.33M 0.01% 1440
2019
Q3 		$22.5M Buy
252,600
+52,550
+26% +$4.56M 0.01% 1246
2019
Q2 		$16.5M Buy
200,050
+29,900
+18% +$2.34M 0.01% 1436
2019
Q1 		$13.8M Sell
170,150
-30,300
-15% -$2.39M 0.01% 1478
2018
Q4 		$15.2M Sell
200,450
-143,900
-42% -$11.2M 0.01% 1258
2018
Q3 		$27.3M Buy
344,350
+112,850
+49% +$8.54M 0.01% 1083
2018
Q2 		$16.3M Sell
231,500
-283,850
-55% -$20.4M 0.01% 1467
2018
Q1 		$36M Buy
515,350
+74,100
+17% +$5.13M 0.01% 821
2017
Q4 		$30.6M Sell
441,250
-55,200
-11% -$3.72M 0.01% 964
2017
Q3 		$33.6M Sell
496,450
-496,350
-50% -$31.4M 0.01% 869
2017
Q2 		$67.7M Buy
992,800
+306,250
+45% +$20M 0.03% 480
2017
Q1 		$42.8M Buy
686,550
+66,050
+11% +$3.84M 0.02% 638
2016
Q4 		$33.9M Buy
620,500
+483,100
+352% +$27.4M 0.02% 727
2016
Q3 		$9.03M Sell
137,400
-20,100
-13% -$1.31M ﹤0.01% 1603
2016
Q2 		$9.51M Buy
157,500
+49,850
+46% +$2.9M 0.01% 1486
2016
Q1 		$6.06M Sell
107,650
-157,500
-59% -$9.46M ﹤0.01% 2073
2015
Q4 		$18M Sell
265,150
-34,500
-12% -$2.26M 0.01% 1224
2015
Q3 		$19.1M Sell
299,650
-65,650
-18% -$4.32M 0.01% 1243
2015
Q2 		$23.3M Buy
365,300
+117,200
+47% +$8.02M 0.01% 1176
2015
Q1 		$17M Sell
248,100
-453,700
-65% -$31.5M 0.01% 1372
2014
Q4 		$49.4M Sell
701,800
-1,075,100
-61% -$77M 0.02% 735
2014
Q3 		$127M Buy
1,776,900
+266,500
+18% +$19.5M 0.05% 343
2014
Q2 		$112M Buy
1,510,400
+1,377,900
+1,040% +$99.6M 0.05% 336
2014
Q1 		$8.6M Sell
132,500
-68,200
-34% -$4.4M ﹤0.01% 2191
2013
Q4 		$11.9M Buy
200,700
+28,600
+17% +$1.55M 0.01% 1849
2013
Q3 		$8.94M Buy
172,100
+62,300
+57% +$3.13M ﹤0.01% 2018
2013
Q2 		$5.19M Buy
+109,800
New +$5.59M ﹤0.01% 2571

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Susquehanna International Group's AZN Position: Q1 2026 in Review

Susquehanna International Group increased its AstraZeneca (AZN) stake by 816% in Q1 2026, buying an estimated $23.5M and bringing the position to 136,541 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

Susquehanna International Group first reported a position in AZN in Q3 2013 and has held it in 48 quarters since. The position peaked at $173M in Q3 2021. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Susquehanna International Group held 136,541 shares of AstraZeneca worth $26.9M as of Q1 2026.
  • Susquehanna International Group bought 121,634 AstraZeneca shares in Q1 2026, an estimated $23.5M.
  • AstraZeneca made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1872 holding.
  • Susquehanna International Group first reported a position in AstraZeneca in Q3 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's AstraZeneca position peaked at $173M in Q3 2021.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.